We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

122 hedge funds and large institutions have $331M invested in Dynavax Technologies in 2016 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 41 increasing their positions, 29 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more call options, than puts

Call options by funds: $55.3M | Put options by funds: $27.6M

41% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 29

4% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 24

1% more funds holding

Funds holding: 121122 (+1)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

30% less capital invested

Capital invested by funds: $470M → $331M (-$139M)

Holders
122
Holders Change
+1
Holders Change %
+0.83%
% of All Funds
3.25%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
25
Increased
41
Reduced
29
Closed
24
Calls
$55.3M
Puts
$27.6M
Net Calls
+$27.7M
Net Calls Change
-$1.16M
Name Holding Trade Value Shares
Change
Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$3.35M -$1.04M -72,355 -18%
CC
27
CQS Cayman
Cayman Islands
$3.32M +$3.04M +211,500 +201%
PAM
28
Panagora Asset Management
Massachusetts
$3.16M -$569K -39,567 -12%
RPAM
29
Rhenman & Partners Asset Management
Sweden
$3.15M +$2.16M +150,000 +100%
CWG
30
C WorldWide Group
Denmark
$3.12M +$1.55M +107,500 +57%
Axa
31
Axa
France
$2.9M +$1.32K +92 +0%
Geode Capital Management
32
Geode Capital Management
Massachusetts
$2.76M +$49.4K +3,436 +1%
Citadel Advisors
33
Citadel Advisors
Florida
$2.66M +$3.23M +224,626 +782%
EAM
34
Eventide Asset Management
Massachusetts
$2.62M
PC
35
Paulson & Co
New York
$1.82M
CCM
36
Clovis Capital Management
New York
$1.76M -$3.57M -248,490 -60%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$1.75M -$296K -20,626 -11%
RSCM
38
Rock Springs Capital Management
Maryland
$1.73M
DA
39
DSC Advisors
Illinois
$1.63M
BIM
40
BlackRock Investment Management
Delaware
$1.6M +$73.1K +5,086 +3%
UBS Group
41
UBS Group
Switzerland
$1.6M +$1.61M +111,686 +273%
JP Morgan Chase
42
JP Morgan Chase
New York
$1.42M +$1.95M +135,400 New
EAM
43
EverPoint Asset Management
Connecticut
$1.36M +$1.87M +130,000 New
Charles Schwab
44
Charles Schwab
California
$1.35M -$47.7K -3,318 -3%
CA
45
Claar Advisors
New York
$1.31M
LCM
46
Laurion Capital Management
New York
$1.27M +$1.74M +121,320 New
RA
47
Royce & Associates
New York
$1.26M -$632K -44,000 -27%
HT
48
HAP Trading
New York
$1.21M +$1.66M +115,639 New
Nordea Investment Management
49
Nordea Investment Management
Sweden
$1.13M +$917K +63,792 +147%
PI
50
Putnam Investments
Massachusetts
$1.12M -$995K -69,236 -39%

DVAX Hedge Fund Activity: Q3 2016 in Review

122 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q3 2016, worth a combined $331M — down 30% from $470M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new DVAX positions and 24 closed out — a net gain of 1 holder — while 41 added to existing stakes and 29 trimmed.

The largest buyer was William Blair & Company, adding an estimated $19.6M. The largest seller was OrbiMed, exiting entirely with an estimated $35M sold.

  • 122 institutional investors held Dynavax Technologies (DVAX) as of Q3 2016, up from 121 in Q2 2016.
  • Funds reported $331M of Dynavax Technologies stock for Q3 2016, down 30% quarter-over-quarter.
  • 25 funds opened new Dynavax Technologies positions in Q3 2016 and 24 closed out, a net change of +1 holder.
  • The largest Dynavax Technologies buyer in Q3 2016 was William Blair & Company, an estimated $19.6M added.
  • The largest Dynavax Technologies seller in Q3 2016 was OrbiMed, an estimated $35M sold.

Based on aggregated 13F filings for Q3 2016.